Skip to main content

Viral Conjunctivitis

0
Pipeline Programs
1
Companies
5
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

NicOx
NicOxFrance - Biot
5 programs
ADenoVirus Initiative Study in Epidemiology in FranceN/A1 trial
ADenoVirus Initiative Study in Epidemiology in GermanyN/A1 trial
ADenoVirus Initiative Study in Epidemiology in ItalyN/A1 trial
ADenoVirus Initiative Study in Epidemiology in SpainN/A1 trial
ADenoVirus Initiative Study in Epidemiology in UKN/A1 trial
Active Trials
NCT02054234Completed357Est. Dec 2014
NCT02054273Completed240Est. Jun 2015
NCT03055065Completed241Est. Oct 2015
+2 more trials

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
NicOxADenoVirus Initiative Study in Epidemiology in UK
NicOxADenoVirus Initiative Study in Epidemiology in Italy
NicOxADenoVirus Initiative Study in Epidemiology in Spain
NicOxADenoVirus Initiative Study in Epidemiology in Germany
NicOxADenoVirus Initiative Study in Epidemiology in France

Clinical Trials (5)

Total enrollment: 1,255 patients across 5 trials

NCT02112773NicOxADenoVirus Initiative Study in Epidemiology in UK

ADenoVirus Initiative Study in Epidemiology in UK

Start: Feb 2015Est. completion: Jun 201531 patients
N/ACompleted
NCT03055065NicOxADenoVirus Initiative Study in Epidemiology in Italy

ADenoVirus Initiative Study in Epidemiology in Italy

Start: Nov 2014Est. completion: Oct 2015241 patients
N/ACompleted
NCT02254330NicOxADenoVirus Initiative Study in Epidemiology in Spain

ADenoVirus Initiative Study in Epidemiology in Spain

Start: Jul 2014Est. completion: Aug 2015386 patients
N/ACompleted
NCT02054273NicOxADenoVirus Initiative Study in Epidemiology in Germany

ADenoVirus Initiative Study in Epidemiology in Germany

Start: Apr 2014Est. completion: Jun 2015240 patients
N/ACompleted
NCT02054234NicOxADenoVirus Initiative Study in Epidemiology in France

ADenoVirus Initiative Study in Epidemiology in France

Start: Jun 2013Est. completion: Dec 2014357 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.